QualityStocksNewsBreaks Archives - Page 560 of 1452

ThursdayNov 11, 2021 12:07 pm

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Announces Strategic Coffee Business Acquisitions

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced its acquisition of a majority equity interests in each of Eh Coffee Corp. and Portfolio Coffee Inc. from their respective shareholders for a purchase price comprised of common shares of PlantX and cash. With the acquisition, PlantX intends to sell the companies’ products via its online platform and physical locations. In addition, PlantX will exclusively use the curated beans to make coffee beverages in its state-of-the-art cafes located in XMarket Squamish, XMarket Venice Beach, XMarket Hillcrest, XMarket Tel Aviv, and the two upcoming XMarkets located in Hudson’s Bay stores (Yorkdale and…

ThursdayNov 11, 2021 11:08 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at Jefferies London Healthcare Conference

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced that its CEO Doug Drysdale will present at the Jefferies London Healthcare Conference. The event is slated to be held in a virtual format from Nov. 18-19, 2021. Drysdale’s presentation will be available on demand beginning at 8:00 a.m. GMT on Thursday, Nov. 18 through 5:00 p.m. GMT on Friday, Nov. 19. Interested parties should visit https://ibn.fm/LREaZ to register for the webcast and view the presentation. An archived webcast will be available on the company’s investor relations website. To view the full press release, visit https://ibn.fm/Xhp0W…

ThursdayNov 11, 2021 10:41 am

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Enters Partnership to Develop Next-Generation Hearing Aids, Hearable Products

InnerScope Hearing Technologies (OTC: INND), a leader in direct-to-consumer (“DTC”) and over-the-counter (“OTC”) hearing solutions, is partnering with Atlazo Inc. The two companies will work together to develop next-generation hearing aids and hearable products, utilizing Atlazo’s patented artificial intelligence (“AI”) hardware platform. InnerScope is confident that products powered by Atlazo’s proprietary ultra-low power System-on-Chip (“SoC”) technology will include unprecedented new features such as voice commands, continuous health monitoring, and seamless connectivity with other smart devices. The company notes that consumers will not only enjoy improved hearing in noisy environments but also find natural ways to interact with other wireless devices, including…

ThursdayNov 11, 2021 10:02 am

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) First-Ever Meet Delic Experience Ranks as World’s Largest Psychedelic and Wellness Event

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has released information regarding its inaugural Meet Delic event, which was held last week in Las Vegas. The company noted that the event was sold out, with more than 2,500 people in attendance, making the psychedelic edutainment experience and business expo the largest in the world. The event agenda featured 20 hours of talks, panels and discussions presented by more than 60 thought leaders, medical professionals and wellness advocates. The company has already released dates for the next year’s Meet Delic…

WednesdayNov 10, 2021 2:31 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Eyeing Opportunities in the US, UK and EU, Generating Interest Among Latin American and Caribbean Countries

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) was featured in a recent “Bell2Bell” podcast episode in which CEO Hector Bremner discussed the company’s history, its goals and the plans it has for development further down the road. “Avricore’s flagship HealthTab(TM) platform partners currently with Abbott Rapid Diagnostics’ Afinion 2(TM) and ID Now(TM) analyzers, as well as Abaxis Global Diagnostics’ Piccolo Xpress to conduct blood or molecular testing at a neighborhood pharmacy and then shares the data from tests not only with the patient but also with medical professionals and researchers without compromising health privacy,” reads a recent article. Avricore accomplished the…

WednesdayNov 10, 2021 2:07 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Supporting and Promoting Artists at Every Stage

Friendable (OTC: FDBL), a mobile technology and marketing company, recently announced a unique opportunity for artists on the Fan Pass live streaming platform. Titled “Double Down” October, the contest gave artists on the platform the opportunity to double the revenue they earned for the entire month. For every dollar that an artist made, Friendable matched it on all ticket and merchandise sales. The top three revenue-earning artists for the month also received additional monetary prizes. “Robert A. Rositano Jr., CEO and co-founder of Friendable, said Fan Pass continues to look for ways to promote its artist members while also providing…

WednesdayNov 10, 2021 1:23 pm

QualityStocksNewsBreaks – LQwD Fintech Corp. (TSX.V: LQWD) (OTC: LQWDF) Announces Entry into Strategic Agreement, Increase of Bitcoin Holdings

LQwD Fintech (TSX.V: LQWD) (OTC: LQWDF), a Bitcoin Lightning Network focused company developing institution-grade payment infrastructure and solutions, today announced its entry into an agreement with Israeli-based Breez Development Ltd., a leading Lightning Network service provider. As part of the agreement, LQwD intends to offer Lightning Network liquidity services to Breez clients and provide on-demand Lightning Network channels whenever required. In addition, LQwD will run one or more Breez-modified Lightning Network routing nodes and, upon completion of services, Breez will add LQwD as a liquidity partner. “We are excited to work with Breez and become a liquidity partner within the…

WednesdayNov 10, 2021 1:09 pm

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FRA:7CR) to Upsize Previously Announced Financing to Further Support Growth Initiatives

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA:7CR), a propriety software-as-a-service (“SaaS”) technology company delivering mobile live dealer technology to online gaming operators globally, has announced that, as a result of strong and continued investor demand and further to the company's news releases dated Oct. 28 and Nov. 3, 2021, it intends to further upsize its previously announced non-brokered private placement (the “proposed offering”) of units of the company. According to the update, the upsized proposed offering is expected to be for gross proceeds of up to $10,500,000 through the sale of up to 35,000,000 units, each at a price of…

WednesdayNov 10, 2021 12:44 pm

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) CMO to Participate in Horizons’ Veterans & Families Forum

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, has announced that chief medical officer Dr. Rakesh Jetly will be part of the Horizons' Veterans & Families Forum. The forum is scheduled for Nov. 10, and Jetly will be a panel member for a presentation titled “The State of Care and the Case for Psychedelic Therapy.” The panel will begin at 7:30 p.m. The event is designed specifically for veterans and will be held in NYC at the Judson Memorial Church; a virtual webcast will…

WednesdayNov 10, 2021 11:25 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Financial Results, Business Updates for Q1 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, has reported its financial numbers and corporate update for first-quarter 2022, the period ended Sept. 30, 2021. Highlights of the report included the company’s completion of the BayMedica acquisition, positioning InMed as an industry leader in the manufacturing and commercialization of rare cannabinoids. In addition, InMed is focused on the process optimization of IntegraSyn(TM) as a solution for large-scale, pharmaceutical-grade Good Manufacturing Practice (“GMP") rare cannabinoid production. The company is also continuing the preclinical studies of its exclusive glaucoma program, INM-088, in preparation for human…

Site Search

Company Search

Category: QualityStocksNewsBreaks